Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

TEIGER

Showing results (281-290 of 290) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 290 results.
Lancet (London, England)|May 25, 2024
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trialAndreas Baumbach, Niels van Royen, Ignacio J Amat-Santos, et al.
The New England Journal of Medicine|May 4, 2012
Registry of transcatheter aortic-valve implantation in high-risk patientsMartine Gilard, Hélène Eltchaninoff, Bernard Iung, et al.
Circulation|November 19, 2019
Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI RegistryEric Van Belle, Flavien Vincent, Julien Labreuche, et al.
Journal of the American College of Cardiology|December 12, 2025
1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK TrialPatrick W Serruys, Akihiro Tobe, Niels van Royen, et al.
International Journal of Cardiology. Heart & Vasculature|October 13, 2025
Quantitative videodensitometric assessment of aortic regurgitation in Myval, Sapien, and Evolut THV series: Results from the LANDMARK trialElfatih A Hasabo, Niels van Royen, Ignacio J Amat-Santos, et al.
International Journal of Cardiology|April 27, 2026
Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trialAkihiro Tobe, Pieter C Smits, Niels van Royen, et al.
European Heart Journal. Cardiovascular Imaging|August 28, 2025
Comparative 30-day Echocardiographic Outcomes of Myval versus Sapien and Evolut THVs: Insights from LANDMARK TrialOsama Soliman, Elfatih A Hasabo, Niels van Royen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2024
Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosisNiels van Royen, Ignacio J Amat-Santos, Martin Hudec, et al.
Journal of the American College of Cardiology|July 1, 2017
Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVIVincent Auffret, Thierry Lefevre, Eric Van Belle, et al.
Journal of the American College of Cardiology|March 24, 2017
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve StenosisSung-Han Yoon, Sabine Bleiziffer, Ole De Backer, et al.
Pageof 29

Showing results (281-290 of 290) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 290 results.
Lancet (London, England)|May 25, 2024
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trialAndreas Baumbach, Niels van Royen, Ignacio J Amat-Santos, et al.
The New England Journal of Medicine|May 4, 2012
Registry of transcatheter aortic-valve implantation in high-risk patientsMartine Gilard, Hélène Eltchaninoff, Bernard Iung, et al.
Circulation|November 19, 2019
Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI RegistryEric Van Belle, Flavien Vincent, Julien Labreuche, et al.
Journal of the American College of Cardiology|December 12, 2025
1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK TrialPatrick W Serruys, Akihiro Tobe, Niels van Royen, et al.
International Journal of Cardiology. Heart & Vasculature|October 13, 2025
Quantitative videodensitometric assessment of aortic regurgitation in Myval, Sapien, and Evolut THV series: Results from the LANDMARK trialElfatih A Hasabo, Niels van Royen, Ignacio J Amat-Santos, et al.
International Journal of Cardiology|April 27, 2026
Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trialAkihiro Tobe, Pieter C Smits, Niels van Royen, et al.
European Heart Journal. Cardiovascular Imaging|August 28, 2025
Comparative 30-day Echocardiographic Outcomes of Myval versus Sapien and Evolut THVs: Insights from LANDMARK TrialOsama Soliman, Elfatih A Hasabo, Niels van Royen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2024
Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosisNiels van Royen, Ignacio J Amat-Santos, Martin Hudec, et al.
Journal of the American College of Cardiology|July 1, 2017
Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVIVincent Auffret, Thierry Lefevre, Eric Van Belle, et al.
Journal of the American College of Cardiology|March 24, 2017
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve StenosisSung-Han Yoon, Sabine Bleiziffer, Ole De Backer, et al.
Pageof 29